Nutrinia Overview

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Nutrinia General Information

Description

Developer of an oral insulin formulation intended to help parents feed premature infants and children. The company's insulin formulation reduces intolerance of enteral nutrition and helps to treat rare conditions of the gastrointestinal tract, enabling infants to absorb food and consequently have improved growth velocity and weight gain.

Contact Information

Website
www.nutrinia.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 6 Ha'khilazon Street
  • 5th Floor
  • Ramat Gan 5252270
  • Israel
+972
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 6 Ha'khilazon Street
  • 5th Floor
  • Ramat Gan 5252270
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nutrinia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 01-May-2020 Completed Out of Business
7. Later Stage VC (Series D) 18-Aug-2016 Completed Generating Revenue
6. Later Stage VC Completed Generating Revenue
5. Later Stage VC (Series C) 08-Dec-2014 Completed Generating Revenue
4. Early Stage VC 09-Nov-2008 Completed Startup
3. Early Stage VC Completed Startup
2. Early Stage VC (Series A) 22-Jun-2005 $1000K $1.9M Completed Startup
1. Accelerator/Incubator 01-Jan-2003 $900K $900K Completed Startup
To view Nutrinia’s complete valuation and funding history, request access »

Nutrinia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C1
Series B1
Series B 2,613,335 $1.15 $1.15 1x $1.15 20.52%
Series A 1,269,685 $2.68 $2.68 1x $2.68 9.97%
To view Nutrinia’s complete cap table history, request access »

Nutrinia Patents

  • 35

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Nutrinia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200113977-A1 Multiparticulate granulate comprising insulin Inactive 12-Jun-2017
AU-2017237164-A1 Use of insulin for promoting gastric emptying Inactive 24-Mar-2016
US-20150209412-A1 Insulin-containing infant formula Inactive 31-May-2012
US-20150086622-A1 Growth enhancement of infants Inactive 18-Apr-2012
CA-2870091-A1 Growth enhancement of infants Inactive 18-Apr-2012 A61K9/48
To view Nutrinia’s complete patent history, request access »

Nutrinia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Nutrinia FAQs

  • Where is Nutrinia headquartered?

    Nutrinia is headquartered in Ramat Gan, Israel.

  • What is the size of Nutrinia?

    Nutrinia has 3 total employees.

  • What industry is Nutrinia in?

    Nutrinia’s primary industry is Drug Discovery.

  • Is Nutrinia a private or public company?

    Nutrinia is a Private company.

  • What is Nutrinia’s current revenue?

    The current revenue for Nutrinia is .

  • How much funding has Nutrinia raised over time?

    Nutrinia has raised $53.1M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »